Tech Differentiators

AccendoWave's super power is a new standard of pain care - that provides objective pain data versus the current standard of subjective data. AccendoWave has three solutions: Digital Opioid Alternative - Hospitals are required by their regulator The Joint Commission (TJC) to provide a Non Pharma Pain Treatment Modality. This requirement is due to the Opioid Crisis. There are other evidence based non pharma pain modalities, like VR for pain, acupuncture, physical therapy, but these non pharma solutions provide no real-time quantified patient data. Only AccendoWave's digital drug provides real-time patient data: average & maximum level of pain, patient satisfaction and usage time. AccendoWave provides a complementary Non Pharma Pain Intervention Data Report for hospitals prior to their Joint Commission survey to demonstrate compliance with TJC requirement. Remote Pain Monitoring - AccendoWave is uniquely able to quantify individual pain by comparing your brain waves with your perception of pain (AccendoWave provides a number - you may be 1.83 or 2.57). The individual pain data can be used for care pathways to reduce the cost of care. AccendoWave has no competition to date. Largest Global Benchmarked (specialty, gender, age) Real-Time Pain Database - With Nine Objective Benchmarked Pain Databases, AccendoWave is a health equity solution. AccendoWave provides objective data to address maternal and women's health initiatives. The pain databases can be used by biotech/pharma companies to better match drugs to gender response. Currently, 80% of pain research is done on human men and male mice - 70% of chronic pain is women. AccendoWave has no competition to date.